C oronary heart disease is a leading cause of death worldwide. In particular, coronary heart disease (CHD) annually results in 502 000 deaths in the United States and >700 000 deaths in China. 1, 2 CHD is a common complex disorder that can be caused by single gene or multifactorial conditions resulting from interactions between environmental and inherited risk factors. [3] [4] [5] Efforts to identify genetic determinants of CHD have been directed primarily at nuclear genes. 6 Genome-wide association studies in the population of European and Asian ancestries have identified several genetic loci that are associated with risk of CHD. [7] [8] [9] However, the role of mitochondrial genetic defects in the development of coronary heart disease remains poorly understood. 10, 11 The human mitochondrial genome encodes 13 peptides for the oxidative phosphorylation system, 2 rRNAs, and 22 tRNAs required for mitochondrial protein synthesis. 12 Among these tRNAs, tRNA Thr are in the guanine-rich heavy strand. 12, 13 Mitochondrial tRNA genes are the hot spots for mutations associated with cardiovascular disorders such as hypertension. [14] [15] [16] [17] These hypertension-associated tRNA mutations included the T4291C and A4263G mutations in the tRNA Ile gene, the A4435G mutation in the tRNA Met gene, and the A4401G mutation at the junction of the tRNA Met and tRNA Gln genes.
It is anticipated that mutations in mitochondrial tRNA genes are associated with coronary heart disease. To investigate the role of mitochondrial genetic defects in the development of coronary heart disease, we carried out a systematic and extended mutational screening of 22 tRNA genes in a cohort of 80 Han Chinese subjects with coronary heart disease. Mutational analysis of these tRNA genes in these subjects identified 16 nucleotide changes in 9 tRNA genes. These tRNA variants were further evaluated by phylogenetic analysis, structure-function relation, and allelic frequency of these variants in the Han Chinese controls from the same region.
Methods Subjects
A total of 80 genetically unrelated Chinese subjects with coronary heart disease, aged 33 to 79 years old from Beijing, along with some of their family members, were enrolled in this study under an institutional review boardapproved protocol of informed consent at the Zhejiang University Institutional Review Board and Ethics Committee of Beijing Anzhen Hospital, China. Members of these families were interviewed and evaluated to identify both personal and medical histories of CHD and other clinical abnormalities. The 512 control DNA samples were obtained from a panel of unaffected Han Chinese individuals from the same area.
Subjects underwent a physical examination and laboratory assessment of cardiovascular disease risk factors. A heart function evaluation and measurement of systolic and diastolic blood pressure of subjects were performed as detailed elsewhere. 20 All patients underwent a heart function evaluation by electrocardiography. Signals from the first 10 seconds of the conventional electrocardiography recording were analyzed automatically in software to quantify all major intervals, axes, and voltages as well as ST-segment levels. The initial candidate criteria used for defining these strictly conventional 12-lead electrocardiograms were as follows. Eligible patients had ≥10 minutes of ischemic symptoms at rest and presented with 1 of the following: elevated markers of myonecrosis, ≥0.1 mV of ST depression, or diabetes mellitus. Patients were referred for angiography for suspected myocardial ischemia such as myocardial infarction or unstable angina and myocardial infarction as symptoms and increased troponin I, with or without ST elevation on the electrocardiogram. Coronary angiography was performed by the Judkins technique, and images of the coronary tree were obtained in routine, standardized projections. The angiograms were assessed by ≥2 cardiologists. Coronary angiograms were visually evaluated by 3 independent experienced observers according to the clinical review process. Localization and percentage of luminal diameter reduction were documented for any coronary artery with a stenosis. Significant coronary artery stenosis was defined as luminal diameter reduction of 50%. Patients without angiographic lesions were considered the patients without CHD. 21 Hypertension, hyperlipidemia, diabetes mellitus, cigarette smoking, and family history for CHD were considered risk factors. Diabetes mellitus was defined as hyperglycemia requiring antidiabetic drugs or fasting blood sugar >126 g/ dL. Patients reporting cigarette use during the year prior to examination were considered smokers. Hyperlipidemia was defined as plasma low-density lipoprotein cholesterol >130 mg/dL or total cholesterol >200 mg/dL or using lipid-lowering drugs at the time of investigation. Overweight for Chinese subjects was defined as body mass index >24.
Mutational Analysis of Mitochondrial Genome
Genomic DNA was isolated from the whole blood of participants using Puregene DNA Isolation Kits (Gentra Systems, Minneapolis, MN). The fragments spanning all 22 of the tRNA genes of 80 subjects with CHD and 512 control subjects were PCR-amplified by use of sets of the light-strand and the heavystrand oligonucleotide primers ( Table 1) . The entire mitochondrial genomes of 3 probands (BJH24-II-2, BJH15-III-2, and BJH45-III-7) were PCR-amplified in 24 overlapping fragments by use of sets of the light-strand and the heavy-strand oligonucleotide primers, as described elsewhere. 22 Each fragment was purified and subsequently analyzed by direct sequencing in an ABI 3700 automated DNA sequencer using a Big Dye Terminator Cycle sequencing reaction kit. The resultant sequence data were compared with the updated consensus Cambridge sequence (GenBank accession number: NC_012920).
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Structural Analysis
The published secondary structures for the tRNAs were used to define the stem-and-loop structure.
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Phylogenetic Analysis 
Statistics Analysis
Statistical analyses were performed using the SSPS statistical package, version 16.0, and statistical significance was established at P<0.05. We performed Fisher's exact test to evaluate the difference in mitochondrial tRNA mutations between CHD patients and controls.
Results
Study Samples
The patients in the study samples suffering from coronary heart disease alone or with other clinical phenotypes including hypertension, diabetes mellitus, and cerebrovascular disease, consisted of 57 men and 23 women. Clinical data for these 80 subjects are summarized in Table 3 . All participants were Han Chinese from the Beijing area. Of these, 22 subjects only exhibited coronary heart disease. In addition to coronary heart disease, 40 subjects suffered from hypertension, 5 individuals had diabetes mellitus, 9 subjects exhibited hypertension and diabetes mellitus, 2 individuals had diabetes mellitus and cerebrovascular disease, 1 subject exhibited hypertension and cerebrovascular disease, and 1 subject suffered from hypertension, diabetes mellitus, and cerebrovascular disease. The age at onset of coronary heart disease in all participants ranged from 33 to 79 years, with a median age of 61 years. The age at onset of hypertension in 51 subjects varied from 15 to 77 years, with a median age of 48.8 years, whereas the age at onset of diabetes mellitus in 17 subjects ranged from 38 to 71 years, with an average age of 52.8 years. Body mass index of all participants ranged from 18.03 to 31.64, with an average of 25.39. Forty-two of 80 subjects were smokers. A total of 512 unaffected Han Chinese subjects were obtained from the same area. The age 24 All the nucleotide changes were verified by sequence analysis of both strands and appeared to be homoplasmy. Among 80 subjects with coronary heart disease, 25 subjects carried 1 tRNA variant, whereas none of other 55 subjects harbored any mitochondrial tRNA variant.
Evaluation of Mitochondrial tRNA Variants
To identify putative deleterious mutation, these variants were further evaluated using the following 3 criteria: (1) Figure 1 , 9 variants were located at the loops, whereas 6 variants occurred in the stems of tRNAs. As shown in Table 4 and Figure 1 , the A5592G variant in tRNA Ala created a putative C-G base-pairing, whereas variants G5821A in tRNA Cys and T15889C, G15927A, G15928A, and A15951G in tRNA Thr abolished putative base pairing(s). In addition, a phylogenetic analysis was performed by comparing the human tRNA nucleotide variants with those in 16 other vertebrates. As shown in Table 4 , CI among the variants ranged from 12.5% (tRNA Thr G15930A variant) to 100% (tRNA Ala A5592G and tRNA Glu A14693G variants). In particular, the CI of 7 variants was >75%, the CI of 6 other variants was between 75% and 50%, and the CI of the remaining variants was <50%. These variants were then evaluated by examining the allelic frequency in 512 Han Chinese controls and 2704 control mtDNAs. 25 The T7546C
variant was absent in both this Chinese control population and the 2704 mtDNAs. Five variants were absent in this cohort of Chinese controls and <1% in the 2704 mtDNAs, whereas the allelic frequency of 10 other variants was >1% in this control population and/or in the 2704 mtDNAs. Based on these criteria, the tRNA Ala A5592G and tRNA Asp T7546C mutations may have functional significance. In addition, our previous investigation showed that the tRNA Thr G15927G mutation led to a failure in tRNA metabolism. 26 Thus, these 3 tRNA variants are putative mutations associated with coronary heart disease. Furthermore, statistical analysis was carried out using Fisher's exact test to evaluate the difference in mitochondrial tRNA mutations between 80 subjects with CHD and 512 Chinese controls. The variants with P<0.05 were T15889C, G15927A, and G15930A, whereas the P value of 4 variants (A5592G, T7546C, A1005G, and T1007C) was 0.135. The higher P value of these 4 variants may be a result of the small sample size of subjects with CHD.
Clinical and Genetic Characterization of 7 Chinese Subjects Carrying 1 of the Putative Mutations Associated With Coronary Heart Disease
Ten probands and other members in these families carrying 1 of the putative mutations underwent physical examinations and laboratory assessments of cardiovascular disease risk Homo sapiens NC_012920
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Mus musculus NC_006914.1 factors. Three probands, including subject BJH16 carrying the T7546C mutation and subjects BJH22 and BJH41 carrying the G15927A mutation, did not exhibit a family history of coronary heart disease. By contrast, 3 subjects had a family history of coronary heart disease. As shown in Figure 2 , the pedigree of BJH24 carrying the A5592G mutation and the pedigrees of BJH15 and BJH45 harboring the G15927A mutation exhibited maternal transmission of coronary heart disease. In particular, 7 of 11 matrilineal relatives in the pedigree BJH24 and 6 of 17 matrilineal relatives in the pedigree BJH 45 suffered from coronary heart disease, whereas none of the affected fathers' offspring in these 2 families had clinical abnormalities. In the pedigree BJH15, 10 of 13 matrilineal relatives exhibited coronary heart disease, whereas all affected fathers with CHD, except subject II-3 who married affected subject II-4, never transmitted the trait to their offspring. These features are the maternal transmission of coronary heart disease in these 3 families.
Bos taurus
DM FBG (mmol/L) TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L
Mutational Analysis of Mitochondrial Genomes
To assess the contribution that mtDNA variants or haplogroups make toward the phenotypic expression of these putative mtDNA mutations in these Chinese pedigrees, we performed PCR amplification of fragments spanning the entire mtDNA and subsequent DNA sequence analysis in 2 probands carrying the G15927A mutation and 1 proband carrying the A5592G mutation. The sequence results from these Chinese subjects were aligned with the updated consensus Cambridge sequence. 12 As shown in Table 5 , these probands exhibited distinct sets of mtDNA polymorphisms. These included 27 variants in the D-loop region, 5 known variants in the 12S rRNA gene, 2 known variants in the 16S rRNA gene, the known tRNA Gln A5592G and tRNA Thr G15927A mutations, and the known NC7 9-bp deletion, as well as 29 (2 novel/27 known) silent variants and 11 known missense mutations in the polypeptide-encoding genes. 24 The mitochondrial genomes of subjects BJH15 and BJH45 belonged to the eastern Asian haplogroup B5b, whereas the mtDNA of subject BJH24 resided at haplogroup D4b. 27 These variants in RNAs and polypeptides were further evaluated by phylogenetic analysis of these variants and sequences from 16 other organisms including mouse, 28 bovine, 29 and Xenopus laevis. 30 Only the known CO1 G6969A (I356V) variant of subject BJH45 showed the high conservation in these species, proposed by RuizPesini and Wallace, 23 and had <1% frequency of 2706 mtDNAs. These data suggest that the CO1 G6962A(L356G) variant may have a role in the phenotypic manifestation of the G15927A mutation. By contrast, none of other variants showed both evolutionary conservation and <1% frequency of 2706 mtDNAs.
Discussion
In the present study, we performed a clinical, genetic, and molecular characterization of 80 Han Chinese subjects with and tRNA Thr G15927A mutations were fitted with these criteria, suggesting that these mutations may be associated with coronary heart disease. The first evidence was that the pedigrees of BJH24 carrying the A5592G mutation, BJH15, and BJH45 harboring the G15927A mutation exhibited maternal transmission of coronary heart disease. In particular, 7 of 11 matrilineal relatives in the pedigree BJH24, 6 of 17 matrilineal relatives in the pedigree BJH45, and 10 of 13 matrilineal relatives of pedigree BJH15 suffered from coronary heart disease, whereas none of affected fathers' offspring in these families had clinical abnormalities. The maternal transmissions of coronary heart disease in these 3 families strongly suggest that mutations in mitochondrial DNA are the molecular basis of this disorder in these families. Further sequence analysis of their mitochondrial genomes confirmed the presence of the homplasmic A5592G or G15927A mutations in all matrilineal relatives but not other members of these families. The absence of functionally significant mutations in mtDNAs of probands BJH15-III-2 and BJH24-II-2 indicates that mitochondrial backgrounds may not play an important role in the pathogenesis of coronary heart disease. On the other hand, the CO1 G6962A (L356G) variant may have a role in the phenotypic manifestation of the G15927A mutation in the pedigree of BJH45. The T5592C mutation is localized at a highly conserved uridine (68U) on the acceptor stem of tRNA Ala , where the position is important for the stability and identity of tRNA.
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The U-to-C transition at this position by the T5592C mutation is expected to create a highly conservative base pairing (5G-68C) on the acceptor stem of this tRNA, alter the secondary structure of this tRNA, as in the case of the deafnessassociated tRNA His T12201C mutation. 32 Our previous investigation showed that the T12201C mutation destablized a highly conservative base pairing (5A-68U) on the acceptor stem of this tRNA, leading to a failure in tRNA metabolism. 32 In particular, 70% decrease in tRNA His steady-state level was observed in mutant cells carrying the T12201C mutation, compared with those of controls. These observations further supported the functional significance of the T5592C mutation in the pedigree BJH45 with coronary heart disease. The homoplasmy G15927A mutation is at a highly conserved nucleotide (G42) in the anticodon stem of tRNA Thr , where the position is important for the stability and identity of tRNA. 31 The anticipated destabilization of base pairing (28C-42G) by the G15927A mutation affects secondary structure and function of this tRNA, as in the cases of tRNA Ile A4300G
and tRNA Leu(UUR) T3273C mutations. 33, 34 The G15927A mutation changed the conformation of tRNA Thr , as suggested by slower electrophoretic mobility of mutated tRNA with respect to the wild-type molecule. However, the aminoacylation level of the tRNA Thr was not impaired, but the steadystate level of tRNA was reduced 44% in lymphoblastoid cell lines derived from Chinese control subjects carrying the G15927A mutation. 26 The alteration in tRNA metabolism by the G15927A mutation impaired mitochondrial translation and respiration, increasing the production of reactive oxygen species. 35 The homoplasmic nature of the mtDNA A5592G and G15927A mutations hints at the mild nature of the mutations. These suggest that these mtDNA mutations are by themselves insufficient to produce a clinical phenotype 19, 20, 36 but the inherited risk factors are necessary for the development of coronary heart disease. The nuclear modifier genes and environmental and epigenetic factors, as well as personal lifestyles, may also contribute to the development of coronary heart disease in these subjects carrying the mtDNA mutation. [37] [38] [39] [40] In particular, the tissue specificity of the tRNA Ala A5592G or tRNA Thr G15927A mutation in these Chinese families is likely attributed to tissue-specific tRNA metabolism or the involvement of nuclear modifier genes. In summary, our data provide evidence that mitochondrial genetic defects may lead to coronary heart disease. The mitochondrial tRNA Ala A5592G and tRNA Thr G15927A mutations altered the structure and function of their tRNAs, thereby causing mitochondrial dysfunctions and long-standing increase of reactive oxygen species in cardiovascular cells. These 2 mutations may be the inherited risk factors for coronary heart disease. Thus, our findings may provide new insights into the understanding of the pathophysiology and valuable information for the management and treatment of coronary heart disease. 
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